The Leader in Gene Editing.
LifeEDIT is dedicated to improving human health and quality of life with breakthrough therapeutic and agricultural innovations powered by our unique gene editing systems.
LifeEDIT has built a world-class genome editing platform that houses the largest single collection of RNA-guided nucleases that are active in mammalian cells.
- Broad PAM diversity supports unprecedented access to genomes of interest
- Small nucleases facilitating in vivo delivery for gene therapy
- Versatile editing options available
- Nucleases sourced from non-pathogenic organisms
LifeEDIT is focused on discovery and development of gene therapies for severe genetic disease
LifeEDIT is a discovery-phase life science company that is developing novel therapeutics in Neuroscience, Immuno-oncology and stem cells, as well as innovations in agriculture that address agronomic traits, quality traits and accelerated breeding.
LifeEDIT is a subsidiary of AgBiome – a leading agricultural innovation company with one of the world’s largest collections of sequenced microbial strains. LifeEDIT was formed to develop novel CRISPR-related systems present in this collection and become the leader in new gene editing technologies. LifeEDIT has an experienced leadership team to use these systems to develop breakthrough products.